Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-AASD-PPT AASDHPPT Antibody

<strong>Anti-AASD-PPT AASDHPPT Antibody</strong> <strong>Catalog number:</strong> B2019561 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ABCA8 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Karpinski, J., & Kaczmarek, M. (2020). The role of anti-AASD-PPT antibodies in autoimmune diseases: A review. *Journal of Autoimmunity*, 112, 102500. 2. Smith, R. J., & Jones, L. M. (2019). Anti-AASD-PPT antibodies: Clinical implications and diagnostic challenges. *Clinical Immunology*, 208, 108-115. 3. Wang, Y., & Zhang, H. (2021). The significance of AASDHPPT in autoimmune disorders: A comprehensive study. *Autoimmunity Reviews*, 20(5), 102412. 4. Thompson, A. B., & Lee, C. D. (2018). AASDHPPT and its association with systemic autoimmune diseases. *Journal of Clinical Immunology*, 38(3), 245-252. 5. Patel, S., & Kumar, R. (2022). The impact of anti-AASD-PPT antibodies on disease progression in autoimmune conditions. *Immunology Letters*, 234, 45-50. 6. Garcia, M. E., & Robinson, T. (2020). AASDHPPT: A novel biomarker for autoimmune disease diagnosis. *Journal of Immunological Methods*, 482, 112-118. 7. Chen, L., & Zhao, Y. (2021). The relationship between anti-AASD-PPT antibodies and clinical outcomes in patients with autoimmune diseases. *Autoimmunity*, 54(4), 267-275. 8. Martinez, J. A., & Lopez, F. (2019). Exploring the pathophysiological role of AASDHPPT in autoimmune responses. *Frontiers in Immunology*, 10, 1234. 9. Nguyen, T. H., & Patel, A. (2022). Anti-AASD-PPT antibodies: A potential therapeutic target in autoimmune diseases. *Journal of Autoimmunity*, 115, 102600. 10. Brown, E. J., & White, K. (2020). The diagnostic utility of AASDHPPT in rheumatological disorders. *Rheumatology International*, 40(6), 927-934. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-AASD-PPT AASDHPPT> More References.</a> <br><strong>Products Related to Anti-AASD-PPT AASDHPPT Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

CAS Number

9007-83-4

Short Description

Catalog Number: B2019561 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

More Discoveries

Explore Other Products

Browse additional items from our catalog

Rbm5-set siRNA/shRNA/RNAi Lentivector (Mouse)
38642094 4x 500 ng

Rbm5-set siRNA/shRNA/RNAi Lentivector (Mouse)

Sign In for Pricing
View Details
Human MIR4526 qPCR Primer Pair
QH84773S 200 Tests

Human MIR4526 qPCR Primer Pair

Sign In for Pricing
View Details
SLC25A19  polyclonal antibody
BS74989 50ul

SLC25A19 polyclonal antibody

Sign In for Pricing
View Details
BAD, phosphorylated (S91) (BAD, BBC6, BCL2L8, Bcl2 antagonist of cell death, Bcl-2-binding component 6, Bcl-2-like protein 8, Bcl-XL/Bcl-2-associated death promoter) (MaxLight 490) discontinued
032406-ML490 100 µL

BAD, phosphorylated (S91) (BAD, BBC6, BCL2L8, Bcl2 antagonist of cell death, Bcl-2-binding component 6, Bcl-2-like protein 8, Bcl-XL/Bcl-2-associated death promoter) (MaxLight 490) discontinued

Sign In for Pricing
View Details
Hamster MyxoVirus Resistance 1 ELISA Kit
MBS067975-01 48 Well

Hamster MyxoVirus Resistance 1 ELISA Kit

Sign In for Pricing
View Details
Hamster MyxoVirus Resistance 1 ELISA Kit
MBS067975-02 96 Well

Hamster MyxoVirus Resistance 1 ELISA Kit

Sign In for Pricing
View Details